Silvio Henrique Barberato1, Roberto Pecoits-Filho. 1. Centro de Ciências Biológicas e da Saúde, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil. silviohb@cardiol.br <silviohb@cardiol.br>
Abstract
BACKGROUND: Discrimination of normal from pseudonormal mitral flow is challenging in clinical practice, especially in a milieu of acute plasma volume changes, such as in patients undergoing hemodialysis (HD). Left atrium (LA) enlargement has been recognized as a marker of the duration of left ventricular diastolic dysfunction. We hypothesize that LA volume index (LAVi) may be useful to differentiate normal from pseudonormal left ventricular filling pattern in this scenario. METHODS: Fifty clinically stable patients undergoing HD (of 138 evaluated in a routine examination) in sinus rhythm who had an early to atrial transmitral velocity ratio between 1 and 2 on Doppler echocardiography were selected and divided into normal (n = 28) and pseudonormal (n = 22) groups based on mitral annulus tissue Doppler and pulmonary venous flow data. Receiver operating characteristic curves for LAVi and other echocardiographic parameters were generated to compare the discriminating power between normal and pseudonormal mitral flow. RESULTS: The mean LAVi for patients with normal mitral flow was 24 +/- 6 versus 48 +/- 16 mL/m(2) in those with pseudonormalization (P < .001). LAVi had the best overall performance in comparison with several echocardiographic parameters (area under the curve 0.94, 95% confidence interval 0.84-1.0, P < .001). LAVi greater than 35 mL/m(2) was 91% sensitive and 89% specific for the detection of pseudonormalization in patients undergoing HD. CONCLUSION: Enlargement of LA reflects the chronicity and burden of left ventricular diastolic dysfunction in stable patients undergoing HD with early to atrial transmitral velocity ratio apparently normal on conventional Doppler echocardiography. LAVi is a practical and useful parameter to discriminate normal from pseudonormal mitral flow.
BACKGROUND: Discrimination of normal from pseudonormal mitral flow is challenging in clinical practice, especially in a milieu of acute plasma volume changes, such as in patients undergoing hemodialysis (HD). Left atrium (LA) enlargement has been recognized as a marker of the duration of left ventricular diastolic dysfunction. We hypothesize that LA volume index (LAVi) may be useful to differentiate normal from pseudonormal left ventricular filling pattern in this scenario. METHODS: Fifty clinically stable patients undergoing HD (of 138 evaluated in a routine examination) in sinus rhythm who had an early to atrial transmitral velocity ratio between 1 and 2 on Doppler echocardiography were selected and divided into normal (n = 28) and pseudonormal (n = 22) groups based on mitral annulus tissue Doppler and pulmonary venous flow data. Receiver operating characteristic curves for LAVi and other echocardiographic parameters were generated to compare the discriminating power between normal and pseudonormal mitral flow. RESULTS: The mean LAVi for patients with normal mitral flow was 24 +/- 6 versus 48 +/- 16 mL/m(2) in those with pseudonormalization (P < .001). LAVi had the best overall performance in comparison with several echocardiographic parameters (area under the curve 0.94, 95% confidence interval 0.84-1.0, P < .001). LAVi greater than 35 mL/m(2) was 91% sensitive and 89% specific for the detection of pseudonormalization in patients undergoing HD. CONCLUSION: Enlargement of LA reflects the chronicity and burden of left ventricular diastolic dysfunction in stable patients undergoing HD with early to atrial transmitral velocity ratio apparently normal on conventional Doppler echocardiography. LAVi is a practical and useful parameter to discriminate normal from pseudonormal mitral flow.
Authors: Ricardo João Westphal; Ronaldo Rocha Loures Bueno; Paulo Bezerra de Araújo Galvão; José Zanis Neto; Juliano Mendes Souza; Ênio Eduardo Guérios; Alexandra Cristina Senegaglia; Paulo Roberto Brofman; Ricardo Pasquini; Claudio Leinig Pereira da Cunha Journal: Arq Bras Cardiol Date: 2014-11-04 Impact factor: 2.000
Authors: Jin Ho Hwang; Jun-Bean Park; Yong-Jin Kim; Jung Nam An; Jaeseok Yang; Curie Ahn; In Mok Jung; Chun Soo Lim; Yon Su Kim; Young Hoon Kim; Jung Pyo Lee Journal: Oncotarget Date: 2017-04-05